Science Explorer Back to mapMap
Discussion
Company · Columbia · United States

Ark Therapeutic (United States)

arktherapeutic.comROR OpenAlex
Research works
71
▲ 253% vs 2018-21
Citations
4.8k
68.1 per fractional work
Top-10% rate
15.2%
all institutions 10.0%
Open access
49%
world 40%
International
40%
world 18%
Ark Therapeutic (United States)

Not ranked overall: Ark Therapeutic (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Ark Therapeutic (United States) work in?

In 2022-now, 49% of research at Ark Therapeutic (United States) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (17%). It does 2.2× the world's share of Life Sciences.

Health Sciences: 14 fractional works · 48.8% of its workMedicine: 14 fractional works · 46.9% of its workOncology: 5 fractional works · 18.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 6.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.3% of its workNeurology: 1 fractional works · 3.1% of its workInfectious Diseases: 1 fractional works · 2.5% of its workSurgery: 1 fractional works · 2.2% of its workHematology: 1 fractional works · 2.0% of its workDermatology: 0 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.0% of its workEpidemiology: 0 fractional works · 0.8% of its workImmunology and Allergy: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workOphthalmology: 0 fractional works · 0.6% of its workObstetrics and Gynecology: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.8% of its workHealth Professions: 1 fractional works · 1.9% of its workSpeech and Hearing: 0 fractional works · 1.1% of its workGeneral Health Professions: 0 fractional works · 0.8% of its workLife Sciences: 12 fractional works · 40.5% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 19.2% of its workMolecular Biology: 4 fractional works · 12.1% of its workBiotechnology: 1 fractional works · 3.0% of its workGenetics: 1 fractional works · 2.9% of its workCancer Research: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 5 fractional works · 17.3% of its workImmunology: 5 fractional works · 16.9% of its workVirology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.6% of its workPharmacology: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 5.7% of its workEngineering: 1 fractional works · 4.7% of its workBiomedical Engineering: 1 fractional works · 4.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.7% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.3% of its workChemical Engineering: 0 fractional works · 0.2% of its workBioengineering: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 4.9% of its workPsychology: 1 fractional works · 2.6% of its workClinical Psychology: 1 fractional works · 1.9% of its workApplied Psychology: 0 fractional works · 0.4% of its workSocial Psychology: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.5% of its workEconomics and Econometrics: 0 fractional works · 1.5% of its workSocial Sciences: 0 fractional works · 0.9% of its workDemography: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKArk Therapeutic(United States)30fractional works, 2022-now
Life Sciences41%Physical Sciences6%Health Sciences49%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine1446.9%
    2. Health Professions11.9%
    1. Biochemistry, Genetics and Molecular Biology619.2%
    2. Immunology and Microbiology517.3%
    3. Neuroscience12.0%
    4. Pharmacology, Toxicology and Pharmaceutics01.6%
    5. Agricultural and Biological Sciences00.5%
    1. Engineering14.7%
    2. Materials Science00.7%
    3. Chemical Engineering00.2%
    4. Chemistry00.1%
    1. Psychology12.6%
    2. Economics, Econometrics and Finance01.5%
    3. Social Sciences00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.60× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 17.20× its world share, 5 worksImmunology and Micro…Neuroscience: 1.21× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.42× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.64× its world share, 0 worksChemical EngineeringChemistry: 0.06× its world share, 0 worksChemistryEngineering: 0.31× its world share, 1 worksEngineeringMaterials Science: 0.20× its world share, 0 worksMaterials ScienceHealth Professions: 0.72× its world share, 1 worksHealth ProfessionsMedicine: 2.44× its world share, 14 worksMedicineEconomics, Econometrics and Finance: 0.68× its world share, 0 worksEconomics, Econometr…Psychology: 0.84× its world share, 1 worksPsychologySocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.2×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology17.20×5 works
  2. Pharmacology, Toxicology and Pharmaceutics4.42×0 works
  3. Biochemistry, Genetics and Molecular Biology3.60×6 works
  4. Medicine2.44×14 works
  5. Neuroscience1.21×1 works
  6. Psychology0.84×1 works
  7. Health Professions0.72×1 works
  8. Economics, Econometrics and Finance0.68×0 works
  9. Chemical Engineering0.64×0 works
  10. Engineering0.31×1 works
  11. Materials Science0.20×0 works
  12. Agricultural and Biological Sciences0.11×0 works
  13. Social Sciences0.07×0 works
  14. Chemistry0.06×0 works

Who are the top researchers at Ark Therapeutic (United States)?

Ranked on the quality score, Blaise Bayer lead among researchers whose main affiliation is Ark Therapeutic (United States).

  1. 1 Blaise Bayer United States · #3,195,382 worldwide 3 citations · 25 works
All ranked researchers at Ark Therapeutic (United States)

What are the most cited papers from Ark Therapeutic (United States)?

The most cited paper from Ark Therapeutic (United States) is "Pharmaceutical Particle Engineering via Spray Drying" (Reinhard Vehring, 2007), with 1,690 citations. Next come "Macrophage-Based Approaches for Cancer Immunotherapy" (729) and "Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy" (405).

Most cited papers
#PaperReleasedCitations
1 Pharmaceutical Particle Engineering via Spray Drying Reinhard Vehring · Pharmaceutical Research Open access 26 Nov 2007 1,690
2 Macrophage-Based Approaches for Cancer Immunotherapy Nicholas R. Anderson, Nicholas G. Minutolo, Saar I. Gill et al. · Cancer Research Open access 17 Nov 2020 729
3 Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy Albert M. Maguire, Stephen R. Russell, Jennifer A. Wellman et al. · Ophthalmology Open access 22 Jun 2019 405
4 Neuropilins: structure, function and role in disease Caroline Pellet‐Many, Paul Henry Frankel, Haiyan Jia et al. · Biochemical Journal 27 Mar 2008 391
5 Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells Rafat Abonour, David A. Williams, Lawrence H. Einhorn et al. · Nature Medicine Jun 2000 278
All 63 most cited papers, with filters and sorting

Which keywords describe research at Ark Therapeutic (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Immunity, Tumor Regression, Cancer, Lymphoma, CAR T Cells and Chimeric Antigen Receptor.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Cancer Immunotherapy5▲ 111×3 topics
  2. Immunotherapy5▲ 21×6 topics
  3. Immunity4▲ 33×4 topics
  4. Tumor Regression3▲ 101×2 topics
  5. Cancer3▲ 7.7×11 topics
  6. Inflammation3▲ 4.5×13 topics
  7. CAR T Cells2▲ 114×1 topic
  8. Chimeric Antigen Receptor2▲ 114×1 topic
  9. Lymphoma2▲ 53×2 topics
  10. Innate Immunity2▲ 24×4 topics
  11. Antigen Presentation2▲ 79×2 topics
  12. Dendritic Cells2▲ 79×1 topic
  13. Tumor Antigen2▲ 115×1 topic
  14. Metabolism2▲ 13×5 topics
  15. Gene Therapy2▲ 34×4 topics
  16. Tumor Microenvironment2▲ 14×4 topics
  17. Activation2▲ 81×1 topic
  18. Macrophage2▲ 67×1 topic
  19. Tumor Targeting2▲ 28×3 topics
  20. Oxidative Stress1▲ 2.8×11 topics
  21. Cancer Therapy1▲ 7.5×9 topics
  22. Immune Checkpoint Blockade1▲ 33×1 topic
  23. PD-1 and PD-L11▲ 33×1 topic

Which research topics does Ark Therapeutic (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune cells in cancer and Cancer Immunotherapy and Biomarkers.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksImmune cells in cancer: 2 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksCancer Research and Treatments: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksVirus-based gene therapy research: 1 fractional worksCancer Cells and Metastasis: 1 fractional works
OncologyImmunologyBiotechnologyRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Immunotherapy and Immune Responses Immunology 2 works
  3. 3 Immune cells in cancer Immunology 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Cancer Research and Treatments Biotechnology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  8. 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  9. 9 Virus-based gene therapy research Genetics 1 works
  10. 10 Cancer Cells and Metastasis Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.8%not open51.2%

World: 40% of research is openly available.

with international co-authors39.7%domestic only60.3%

World: 18% is written across borders.

How has Ark Therapeutic (United States)'s research output changed?

Output in 2022-2025 was 253% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ark Therapeutic (United States) as a percentage of every work published that year, 0.00014% in 2024.

still counting0.00020%0.00040%0.00060%Ark Therapeutic (United States)0.000092% in 202519801990200020102020

Fractional works of Ark Therapeutic (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Columbia

All research institutions in Columbia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Ark Therapeutic (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.